Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Rumex obtusifolius* extract is a botanical preparation derived from the broad-leaved dock, a perennial herb widely distributed in temperate regions. The extract is rich in secondary metabolites, including anthraquinones (such as emodin, chrysophanol, and physcion), tannins, and flavonoids. Historically used in traditional medicine for its laxative and skin-healing properties, modern pharmacological research highlights its potent antimicrobial activity against various pathogens, including *Staphylococcus aureus* and *Escherichia coli*. Its mechanism of action involves the disruption of microbial cell membranes and the inhibition of key signaling enzymes like Casein kinase II (CK2). Furthermore, the extract exhibits significant antioxidant and anti-inflammatory effects by scavenging reactive oxygen species and suppressing the NF-kappaB pathway. It is primarily utilized as a dietary supplement or topical herbal remedy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rumex obtusifolius extract.